During a Case-Based Roundtable® event, Sumanta Kumar Pal, MD, discussed long-term outcomes of the TIVO-3 trial in patients ...

If you have any problems with the way your kidneys work. If you are pregnant, trying for a baby or breast-feeding. If you have ever had an allergic reaction to a medicine. This article discusses the ...

Fulvestrant alone isn’t a [definite] option for a patient like this. I probably wouldn't use exemestane plus everolimus ...

3 and a $624m settlement with Novartis in 2020 for using speaker and consulting programmes to promote Afinitor (everolimus) and Gilenya (fingolimod).4 None of the companies admitted wrongdoing. The ...

Consistent with this, the mTOR inhibitors, temsirolimus (Torisel), everolimus (Afinitor), and sirolimus (Rapamune) are being evaluated for anticancer efficacy in hundreds of clinical trials and are ...

Some treatments can cause the results of tumor marker tests to be inaccurate. For example, treatment with the drug Afinitor (everolimus) causes CA 15-3 test results to be the opposite of what they ...